Small cylindrical glass vial (b) stopped with a silver metal cap moulded over the neck and lip, inside a cardboard box (a) with a leaflet (c) containing product information and warnings; liquid vaporized leaving some cream solid residue.
Small cylindrical glass vial (b) stopped with a silver metal cap moulded over the neck and lip, inside a cardboard box (a) with a leaflet (c) containing product information and warnings; liquid vaporized leaving some cream solid residue.
Number Of Parts
3
Part Names
a - box - Size: Length 5.8 cm x Width 2.8 cm x Depth 2.8 cm
b - vial - Size: Depth 5.1 cm x Diam. 2.5 cm
c - leaflet (unfolded) - Size: Length 19.7 cm x Width 10.5 cm
(a) Front: "Pr S-V 57 // CHLOROMYCETIN® // SUCCINATE // CHLORAMPHENICOL // SODIUM SUCCINATE // EQUIVALENT TO: // 1 GRAM // Chloromycetin® // (chloramphenicol, // P.D. & Co.) // INTRAVENOUS // INTRAMUSCULAR // SUBCUTANEOUS // Stock 35-57-1 // PARKE, DAVIS & CO., LTD. // BROCKVILLE, ONTARIO"; right side: "USUAL ADULT DAILY DOSE – 50 mg. per Kg. // See enclosed circular for additional informat- // tion regarding dosage and preparation of // solution. // Sterile solution may be kept at room tempera- // ture for 30 days without significant loss of // potency. A cloudy solution should not be used."; back: "WARNING – Blood dyscrasias may be asso- // ciated with the use of chloramphenicol. It is // essential that adequate blood studies be made. // (See enclosed warnings and precautions.) // Chloromycetin® – Patented in Canada 1951. // Ca. Lic. No. 542 // Exp. Date: April 1970 // Lot No. C239939"; left side: right side repeated in French; top: "Steri-Vial® 57 // 1 GRAM // CHLOROMYCETIN® // SUCCINATE // Stock 35-57-1"; bottom: identical to top; (b) front: "Pr S-V 57 // CHLOROMYCETIN® // SUCCINATE // CHLORAMPHENICOL SODIUM SUCCINATE // EQUIVALENT TO: // 1 GRAM // Chloromycetin® (chloramphenicol, P.D. & Co.) // Stock 35-51-1 // PARKE, DAVIS & CO., LTD. // BROCKVILLE, ONTARIO"; back: "See enclosed circular. // WARNING – Blood dyscrasias may be // associated with the use of chloram- // phenicol. It is essential that adequate // blood studies be made. (See enclosed // warnings and precautions.) // Lot No. C239939 Exp. Date: April 1970 [stamped] // Strength: Date: // Patient: Room:"; bottom: "17 [embossed]"; (c) "FOR PARENTERAL ADMINISTRATION // CHLOROMYCETIN® // (CHLORAMPHENICOL) // WARNING // [text follows] // ANTIMICROBIAL AND PHARMA- // COLOGICAL PROPERTIES OF // CHLORAMPHENICOL // [text follows] // PRODUCTS FOR PARENTERAL USE // AND DOSAGE RECOMMENDATIONS // [text follows] // SIDE EFFECTS OF // CHLORAMPHENICOL THERAPY // [text follows] // PACKAGE INFORMATION // [text follows] // [throughout leaflet, French translation occurs alongside English text] // MEDICAMENTA VERA P D // PARKE, DAVIS & CO., LTD. // BROCKVILLE, ONTARIO // P - TC"
Permanent Location
Storage Room 0010
(a-b) 0010-A3-7 Row G
(c) Instruction Pamphlets + Measuring Aids Binder pg 18 a
Condition Remarks
Box yellowed, dented; vial and leaflet in excellent condition; liquid vaporized leaving some cream solid residue